Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиZynerba Pharmaceuticals Мультипликаторы 2011-2024 | ZYNE
Мультипликаторы по годам Zynerba Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.5 | -2.7 | -1.8 | -3.4 | -1.9 | -5.0 | -6.6 | -2.4 | - | - | - | - |
P/S |
- | - | - | - | 895.4 | - | 21280.6 | 105.8 | - | - | - | - |
EPS |
-0.8 | -0.9 | -1.9 | -1.5 | -2.6 | -2.5 | -2.6 | -2.8 | -6.4 | -1.6 | - | - |
EV (Enterprise Value) |
-22.6 млн | 44.9 млн | 49.1 млн | 53.2 млн | 27 млн | 106 млн | 130 млн | -8.07 млн | 10.3 млн | 2.9 млн | - | - |
EBITDA per Share |
-0.82 | -0.93 | -1.92 | -1.55 | -2.63 | -2.53 | -2.55 | -2.81 | - | - | - | - |
EV/EBITDA |
-0.6 | -0.7 | -1.2 | -0.4 | -3.0 | -5.3 | 1.0 | - | - | - | - | |
PEG |
0.03 | 0.21 | 0.39 | -0.08 | 0.37 | -1.29 | -0.78 | 0.23 | - | - | - | - |
P/B |
0.4 | 1.4 | 1.6 | 1.5 | 1.3 | 2.6 | 5.2 | 0.7 | - | - | - | - |
P/CF |
-0.8 | -3.1 | -2.3 | -3.2 | -2.4 | -6.2 | -7.5 | -3.0 | - | - | - | - |
ROE % |
-75.79 | -52.61 | -85.36 | -43.58 | -69.29 | -52.52 | -79.05 | -31.61 | - | - | - | - |
ROA % |
-63.10 | -45.96 | -69.32 | -37.54 | -59.28 | -46.36 | -63.98 | -28.76 | - | - | - | - |
ROCE % |
-76.25 | -51.85 | -86.56 | -45.33 | -70.13 | -53.27 | -78.44 | -31.56 | - | - | - | - |
Current Ratio |
6.0 | 7.9 | 5.3 | 7.2 | 6.9 | 9.2 | 5.2 | 11.0 | - | - | - | - |
DSO |
- | - | - | - | 14619.6 | - | 181943.3 | 466.8 | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Zynerba Pharmaceuticals
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.21 | -0.21 | - | -0.2 | -0.24 | -0.21 | - | -0.26 | -0.25 | -0.2 | -0.33 | -0.31 | -0.78 | -0.53 | -0.46 | -0.08 | -0.5 | -0.47 | -0.44 | -0.47 | -0.89 | -0.91 | -0.6 | -0.63 | -0.64 | -0.6 | -0.71 | -0.67 | -0.7 | -0.49 | -0.62 | -0.66 | -1.12 | -1.03 | -0.96 | -2.64 | -2.29 | -0.67 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | -0.22 | - | -0.19 | -0.22 | -0.22 | - | -0.25 | -0.24 | -0.2 | -0.35 | -0.31 | -0.83 | -0.46 | -0.49 | -0.08 | -0.52 | -0.49 | -0.46 | -0.48 | -0.88 | -0.92 | -0.61 | -0.65 | -0.64 | -0.64 | -0.69 | -0.67 | -0.71 | -0.48 | -0.62 | -0.66 | -1.12 | -1.03 | -0.96 | -2.63 | -2.27 | -0.49 | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-95.98 | -76.06 | -46.69 | -60.14 | -57.14 | -51.27 | -33.11 | -49.10 | -50.70 | -73.16 | -85.36 | -83.54 | -71.07 | -51.99 | -43.58 | -42.93 | -53.91 | -60.02 | -69.29 | -69.08 | -69.17 | -61.98 | -52.52 | -62.51 | -69.09 | -76.49 | -79.05 | -69.44 | -59.28 | -42.32 | -31.61 | -0.47 | 40.83 | 63.67 | 67.43 | 49.99 | 18.75 | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-75.24 | -63.32 | -40.03 | -51.79 | -49.64 | -45.07 | -29.21 | -42.20 | -42.66 | -59.98 | -69.32 | -68.54 | -58.54 | -43.77 | -37.54 | -36.90 | -46.28 | -51.42 | -59.28 | -59.47 | -59.91 | -54.12 | -46.36 | -53.47 | -57.79 | -62.78 | -63.98 | -57.58 | -50.37 | -37.05 | -28.76 | -28.38 | -40.89 | -50.15 | -46.74 | -34.65 | -13.00 | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-97.44 | -75.09 | -45.78 | -58.76 | -55.63 | -50.83 | -32.43 | -49.37 | -51.75 | -76.85 | -86.56 | -84.72 | -71.92 | -50.83 | -45.40 | -44.27 | -55.58 | -61.13 | -70.13 | -69.63 | -69.79 | -62.73 | -53.85 | -62.98 | -69.23 | -76.74 | -78.44 | -69.49 | -59.28 | -42.14 | -31.56 | -0.48 | 40.82 | 63.66 | 67.42 | 49.98 | 18.75 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
3.5 | 5.0 | 6.0 | 6.5 | 6.9 | 8.1 | 7.9 | 8.0 | 9.3 | 8.3 | 5.3 | 5.3 | 5.3 | 5.3 | 7.2 | 7.2 | 7.2 | 7.2 | 6.9 | 6.9 | 6.9 | 6.9 | 8.5 | 8.5 | 8.5 | 8.5 | 5.2 | 6.8 | - | - | 11.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD